REG - Yourgene Health PLC - Posting of Circular and Notice of General Meeting

Yourgene HealthAnnouncement

23/12/2022 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221223:nRSW6929Ka&default-theme=true

RNS Number : 6929K  Yourgene Health PLC  23 December 2022

 

Yourgene Health plc

("Yourgene" or the "Company")

 

 Posting of Circular and Notice of General Meeting

 

The Board of Yourgene Health plc (AIM: YGEN), is pleased to confirm that,
further to the announcements made on 21 December 2022 and 22 December 2022,
regarding the proposed Capital Raising, a circular (the "Circular"), including
the Notice of General Meeting and a Form of Proxy was posted yesterday to
shareholders.

 

The General Meeting will be held at Skelton House, Lloyd Street North,
Manchester Science Park, Manchester M15 6SH  on 9 January 2023 at 4.00 p.m.

 

A copy of the Circular will shortly be available to download from the
Company's website at
http://www.yourgene-health.com/investors/key-documents/shareholder-communications
(http://www.yourgene-health.com/investors/key-documents/shareholder-communications)
.

 

Unless otherwise defined, all capitalised terms used but not defined in this
announcement shall have the meaning given to them in the Circular.

 

The expected timetable relating to the Capital Raising is set out below.

                                                                                 2022
 Announcement of the Capital Raising                                             21 December

 Announcement of Retail Offer                                                    22 December

 Publication and posting of the Circular and Form of Proxy                       22 December

 First Admission and commencement of dealings in the First Admission Shares      8.00 a.m. on 23 December

 CREST stock accounts expected to be credited for the First Admission Shares     23 December
 (where applicable)

 Launch of Retail Offer                                                          23 December

                                                                                                         2023
 Posting of share certificates for the First Admission Shares by the Registrar   by no later than 5 January
 (where applicable)

 Latest time and date for receipt of Forms of Proxy and CREST voting             5.00 p.m. on 5 January
 instructions

 Close of Retail Offer                                                           6 January

 General Meeting                                                                 4.00 p.m. on 9 January

 Results of the General Meeting announced through a Regulatory Information        9 January
 Service

 Second Admission and commencement of dealings in the Second Admission Shares    8.00 a.m. on 11 January
 and the Retail Shares

 Where applicable, expected date for CREST accounts to be credited in respect    11 January
 of Second Admission Shares in uncertificated form

 Posting of share certificates for the Second Admission Shares by the Registrar  by no later than 24 January
 (where applicable)

 Long Stop Date                                                                   30 January

 

Each of the times and dates above refer to London time and are subject to
change. Any such change will be notified to Shareholders by an announcement
through a Regulatory Information Service. All events listed in the above
timetable following the General Meeting are conditional on the passing of the
Resolutions at the General Meeting.

 

Enquiries:

 

 Yourgene Health plc                                Tel: +44 (0)161 669 8122

 Lyn Rees, Chief Executive Officer                  investors@yourgene-health.com (mailto:investors@yourgene-health.com)
 Barry Hextall, Chief Financial Officer
 Joanne Cross, Director of Marketing

 Cairn Financial Advisers LLP (NOMAD)               Tel: +44 (0)20 7213 0880
 Liam Murray / James Caithie / Ludovico Lazzaretti

 Singer Capital Markets (Corporate Broker)          Tel: +44 (0)20 7496 3000
 Aubrey Powell / Tom Salvesen / George Tzimas

 Walbrook PR Ltd (Media and Investor Relations)     Tel: +44 (0)20 7933 8780 or Yourgene@walbrookpr.com
                                                    (mailto:mayflower@walbrookpr.com)
 Paul McManus / Lianne Applegarth                   Mob: 07980 541 893 / 07584 391 303

 / Alice Woodings                                   / 07407 804 654

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCPPGQCPUPPPUP